Home Tags Catalio Capital Management

Catalio Capital Management

OnCusp Therapeutics, Inc., a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, today announced an oversubscribed $100 million Series A financing round.

[Funding alert]OnCusp Therapeutics Raises Oversubscribed $100 Mn Series A Financing

Startuprise io -
© Copyright startuprise 2024 All Rights Reserved.
Exit mobile version